Dopamine-1 Receptor Defect in Hypertension
Dopamine-1 Receptor Defect in Hypertension
批准号:
7921095
负责人:
Pedro A. Jose
金额:
$17.2万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-09-29
关键词:
AcuteAgonistAngiotensin II ReceptorBindingBloodBlood PressureBrainCellsCholecystokininClathrinClathrin-Coated VesiclesComplementComplexCorpus striatum structureCyclic AMPCyclic AMP-Dependent Protein KinasesDataDefectDevelopmentDopamineDopamine ReceptorDuct (organ) structureEpithelialEssential HypertensionExcretory functionExtracellular FluidFailureFigs - dietaryFunctional disorderFundingG Protein-Coupled Receptor GenesGTP-Binding ProteinsGasesGenesGeneticGenetic TranscriptionGenetic VariationHumanHypertensionImpairmentIn VitroInbred SHR RatsIntakeIntestinesKidneyKnowledgeLeadLigandsLimb structureLinkLysosomesMediatingModelingModificationMusNa(+)-K(+)-Exchanging ATPaseNephronsOrganOxidative StressParathyroid HormonesPathway interactionsPhenotypePhospholipasePhosphotransferasesPhysiologicalProductionProgress ReportsProtein IsoformsProteinsProximal Kidney TubulesReceptor GeneReceptor InhibitionRegulationRenal functionReportingResearch PersonnelRodentSRC geneSecond Messenger SystemsSmall IntestinesSodiumSodium ChlorideSympathetic Nervous SystemSystemTestingThickTransgenic MiceTranslationsUbiquitinationVasoconstrictor AgentsVasodilator Agentsadapter proteinarrestin 2human PTH proteinin vivolate endosomemulticatalytic endopeptidase complexoffspringoverexpressionpressurepreventprogramsprotein expressionprotein protein interactionreceptorreceptor couplingreceptor functionsalt sensitivesalureticsecond messengersorting nexin 1therapeutic targettrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There is substantial evidence for dysfunction of D1-1 ike receptors in hypertension but the precise D1-like
receptor involved remains to be determined. One reason is the lack of D1-like receptor ligands selective to
either of the D1-like receptor subtype, D1R or D5R This limitation has been overcome by the selective
deletion of the D1R and D5R gene in mice: disruption of either receptor gene increases blood pressure and
produces hypertension. Data obtained in previous funding period showed that D5-/- mice are hypertensive
caused, in part, by activation of sympathetic nervous system and increased oxidative stress.
Dopamine and angiotensin II receptors regulate each other and interact to regulate renal function but it is not
known which D1-like receptor, D1R or D5R, regulates AT1R action. In renal proximal tubule cells, 75% of
D1-like receptor function is afforded by D1R while only 25% is due to D5R. However, D1-like receptor
inhibition of renal Na+K+ATPase activity (which is inhibited, in part, by cAMP/PKA) is abrogated and blood
pressure is increased in D5-/- mice, in spite of an intact D1R gene. Because renal AT1R protein is increased
in D5-/- mice, the impairment of D1R action may be due to increased AT1R expression. This in turn causes
salt sensitive hypertension. Indeed, the hypertension of D5-/- is aggravated by increased NaCI intake and
AT1R blockade normalizes blood pressure of D5-/- mice. In renal proximal tubule cells, D5R but not D1R
decreases AT1R protein that cannot be explained by a decrease in transcription or translation. The D5R is
constitutively ubiquitinated and 05R stimulation increases ubiquitination of AT1R. Blockade of proteasomes
prevents the D5R-mediated decrease in AT1R protein expression. These data are corroborated in HEK-293
cells expressing D5R and AT1R. Therefore, the increase in AT1R protein in D5-/- mice may be caused may
be caused by the failure of D5R to down-regulate AT1 R. It is hypothesized that D5R deficiency leads to
increased AT1R expression, sodium sensitivity, and hypertension. Specific aim 1will test the hypothesis
that hypertension in D5-/- mice is, in part, caused by increased renal AT1R expression. Specific aim 2 will
test the hypothesis that the counter regulation of D1-like and AT1Rs are caused by several mechanisms
including protein/protein interaction and proteasomal degradation. Knowledge of the mechanisms bywhich
hypertension develops when D5R function is impaired may lead to the development of targeted therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
D2 receptor variation and renal dysfunction
-
批准号:10564943
-
项目类别:
-
资助金额:$70.6万
-
财政年份:2023
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:9886774
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:10544330
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:10083735
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Lipid rafts, dopamine 1 receptor, and hypertension
-
批准号:10319571
-
项目类别:
-
资助金额:$64.24万
-
财政年份:2020
-
负责人:Pedro A. Jose
-
依托单位:
Ds receptor antioxidant activity and hypertension
-
批准号:8148031
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2010
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:8123257
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:7658921
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:7908700
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and development of salt sensitivity
-
批准号:8266339
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2008
-
负责人:Pedro A. Jose
-
依托单位:
D5 Receptor Antioxidant Activity and Hypertension
-
批准号:7218286
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2006
-
负责人:Pedro A. Jose
-
依托单位:
Animal models of salt sensitivity: roles of GRK4 and sodium transporters on salt sensitivity
-
批准号:9283600
-
项目类别:
-
资助金额:$74.68万
-
财政年份:2004
-
负责人:Pedro A. Jose
-
依托单位:
GRK4 and D3R regulation of NHE3 and NCC expression
-
批准号:7778674
-
项目类别:
-
资助金额:$43.54万
-
财政年份:2004
-
负责人:Pedro A. Jose
-
依托单位:
D3, D1, AT1 Receptor Interaction--Genetic Hypertension
-
批准号:6781667
-
项目类别:
-
资助金额:$56.36万
-
财政年份:2003
-
负责人:Pedro A. Jose
-
依托单位:
D5 receptor antioxidant activity and hypertension
-
批准号:6656540
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2002
-
负责人:Pedro A. Jose
-
依托单位:
ONTOGENY OF DOPAMINE RECEPTOR/G-PROTEIN/EFFECTOR COUPLING
-
批准号:6346138
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2000
-
负责人:Pedro A. Jose
-
依托单位:
ONTOGENY OF DOPAMINE RECEPTOR/G-PROTEIN/EFFECTOR COUPLING
-
批准号:6201931
-
项目类别:
-
资助金额:$18.69万
-
财政年份:1999
-
负责人:Pedro A. Jose
-
依托单位:
ONTOGENY OF DOPAMINE RECEPTOR/G-PROTEIN/EFFECTOR COUPLING
-
批准号:6105772
-
项目类别:
-
资助金额:$18.69万
-
财政年份:1998
-
负责人:Pedro A. Jose
-
依托单位:
DOPAMINE-3 RECEPTOR SUBTYPE AND HYPERTENSION
-
批准号:6043980
-
项目类别:
-
资助金额:$22.07万
-
财政年份:1997
-
负责人:Pedro A. Jose
-
依托单位:
DOPAMINE-3 RECEPTOR SUBTYPE AND HYPERTENSION
-
批准号:2372962
-
项目类别:
-
资助金额:$21.01万
-
财政年份:1997
-
负责人:Pedro A. Jose
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: